Clinical Trial Update: Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device Support [Phase 4]

View source ↗

Summary

Phase 4 trial investigating iron repletion with Feraheme in anemic patients with durable ventricular assist devices; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Feraheme (ferumoxytol)

Snippet

Sponsor: NYU Langone Health | Conditions: Anemia | Phase 4 | Status: TERMINATED | Results posted: 2023-07-18